Futuristic Fat-Fighting Fantasy: Using CRISPR To Tweak ‘Bad’ Fat Into Acting Like ‘Good’ Fat
By Carey Goldberg,
WBUR
| 08. 27. 2020
Here's a sci-fi fantasy spurred by some very real — but early — new research published this week:
Imagine the pounds have been creeping up, so your doctor suggests a bit of CRISPR. Technicians extract some of your white fat cells — also known as "bad" fat cells because they store energy in places like bellies and bulges.
They use the gene-editing tool CRISPR to tweak the cells' genes. Now, those white cells function more like brown fat cells — the "good" kind that burn energy when you're cold or exercise.
Voila: your metabolism is adjusted so that you burn more calories and absorb glucose better. You're set up for weight-control success, instead of the common frustration of weight regain. Current-day liposuction is left in the dust. Your fat hasn't just been removed — it's been reengineered.
Back to current reality: Researchers at the Joslin Diabetes Center in Boston and elsewhere have just published "proof of concept" work that could eventually make that fantasy come true. They used CRISPR to make human white fat cells act more like brown...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...